Nachrichten zur Johnson & Johnson Aktie

ACHV: Looking Ahead to Resubmission

By John Vandermosten, CFANASDAQ: ACHVREAD THE FULL ACHV RESEARCH REPORTAchieve Life Sciences, Inc. (NASDAQ: ACHV) reported second quarter results, introducing…

Why Is Johnson & Johnson (JNJ) Up 4.8% Since Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

This Dividend Aristocrat Posted Record Quarterly Results

Johnson & Johnson shares have quietly delivered a huge gain in 2026 so far, up more than 25%. The gain…

Gunnison Copper swings to profit on Johnson Camp production ramp

Gunnison Copper Corp (TSX:GCU, OTCQB:GCUMF, FRA:3XS0) swung to profitability and posted a sharp jump in revenue in the second quarter,…

140-year-old Dividend King eyes bold update to unlock new growth

Most 140-year-old companies are coasting. Johnson & Johnson (JNJ) is restructuring. And thats the part of the J&J story that…

Johnson Outdoors Reports Fiscal Third Quarter Results

RACINE, Wis., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor…

Jim Cramer Analyzes Johnson & Johnson (JNJ) After Surgical Robotics Milestone

Jim Cramer celebrated a dramatic pivot in market sentiment surrounding Johnson & Johnson (NYSE:JNJ) during Mad Money’s July 23 episode.…

Johnson Controls: AI Demand And Backlog Strength Underpin A Hold

…

J&J’s biotech progress could punish its 2027 profit

Johnson & Johnson (JNJ) just issued one of the weirdest profit warnings in health care. The biotech business decreased its…

Explainer: Can J&J finally put the talc litigation behind it?

After years of failed attempts to resolve thousands of lawsuits alleging that its talc products caused cancer, Johnson & Johnson…

Johnson Controls lifts annual profit forecast on data center demand

Industrial supplier Johnson Controls International raised its full-year profit forecast on Wednesday, anticipating sustained demand for data center-related products and…

Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth

Johnson & Johnsons revenue has grown modestly while Eli Lillys revenue has nearly doubled in two years, narrowing a once-wide…

Johnson Controls Tops Q3 Earnings & Revenue Estimates, Raises FY26 View

JCI beats third-quarter estimates with double-digit organic growth in key markets and raises its fiscal 2026 outlook on strong operating…

J&J-Aktie gefragt: Johnson & Johnson will Talkum-Klagen mit milliardenschwerem Vergleich beilegen

Der US-Pharmakonzern will 5,5 Milliarden US-Dollar zur Beilegung der Klagen bereitstellen. Johnson & Johnson hatte bereits tags zuvor die Konditionen…

ROUNDUP 2: Johnson & Johnson will Talkum-Klagen mit Milliardenvergleich beilegen

(Kurs aktualisiert) NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson hat im jahrelangen…

Rechtsstreit endet mit Vergleich: Krebserregendes Babypuder? US-Firma zahlt Milliarden

Etliche Klägerinnen werfen Johnson & Johnson vor, durch die Verwendung seiner talkumbasierten Babypuder-Produkte an Eierstockkrebs erkrankt zu sein. Der US-Pharmakonzern…

Stocks making the biggest moves premarket: Coca-Cola, Sherwin-Williams, Johnson & Johnson & more

These are the stocks posting the largest moves in early trading.…

ROUNDUP: Johnson & Johnson will Talkum-Klagen mit Milliardenvergleich beilegen

NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson hat im jahrelangen Rechtsstreit um angeblich krebserregende Talkumprodukte…

Johnson & Johnson proposes $5.5B settlement to resolve remaining talc litigation

Johnson & Johnson (NYSE:JNJ) has reached an agreement to resolve tens of thousands of lawsuits in the US alleging that…

Johnson & Johnson will 5,5-Milliarden-Vergleich in Babypuder-Prozessen

War Babypuder von Johnson & Johnson krebserregend? Dazu gibt es seit Jahren eine Klagewelle. Der Konzern will diese nun mit…

Johnson & Johnson will Talkum-Klagen mit milliardenschwerem Vergleich beilegen

NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson hat im jahrelangen Rechtsstreit um angeblich krebserregende Talkumprodukte…

These 3 Companies Reported Record Results and Raised Guidance

Abbott Laboratories, Taiwan Semiconductor, and Johnson & Johnson have all delivered strong earnings releases in the Q2 cycle, with each…

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

Johnson & Johnson ?said on Monday it has reached ?a $5.5 billion settlement that will resolve tens of thousands of…

Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?

Both have very promising futures.…

Insider trades: Johnson & Johnson, TSMC among notable names

…

Johnson & Johnson – Der US-Gesundheitsriese erhält die FDA-Zulassung für seinen Operationsroboter Ottava!

Johnson & Johnson erhält die FDA-Zulassung für seinen Operationsroboter Ottava – zunächst für Oberbauch-Eingriffe wie Magenbypässe. Die Besonderheit: vier Roboterarme,…

Johnson & Johnsons robotic surgery device gets US FDA marketing authorization

Johnson & Johnson said on Wednesday the U.S. ?Food and Drug Administration had granted marketing authorization for its robotic surgery…

Top Analyst Reports for Johnson & Johnson, Lam Research & Seagate

Johnson & Johnson beat Q2 estimates as growth in key drugs, MedTech and its pipeline helps offset Stelara headwinds. Read…

Johnson & Johnson Aktie: Pharma wächst, MedTech bremst

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson Controls (JCI) Stock Looks Stretched On Cash Flow Yet Reasonable On Earnings

After a strong five year run for Johnson Controls International, the stock no longer looks obviously cheap, with the Discounted…

OP-Roboter, Medikamente und Produktionsausbau! J&J hat abgeliefert und dürfte die 100 Mrd. USD knacken!

Hat Johnson & Johnson (i)(JNJ) im 2. Quartal 2026 abgeliefert? Für mich lautet die klare Antwort: Ja! Zwar reagierte die Wall…

ASML erhöht Gesamtjahresausblick - Apple mit starken iPhone-Verkaufszahlen - PayPal-Aktie im Aufwind

Wien (www.aktiencheck.de) - ASML (0%) konnte gestern die Umsatz- und Gewinnerwartungen für das zweite Quartal 2026 übertreffen, so die Analysten…

+++ Geschäftszahlen +++: Johnson & Johnson hebt Jahresziele an

Börsenrallye und ETF-Boom bescheren BlackRock Rekordergebnis +++ BASF hebt nach Gewinnsprung Jahresziele an Chipausrüster ASML steigert Umsatz +++ Der Newsblog.…

Is Johnson & Johnson a Buy After Its Latest Earnings Report?

Investors didnt seem to think so after the company published it.…

Johnson & Johnson Raises 2026 Outlook After Q2 Earnings Beat

Johnson & Johnson raises its 2026 outlook after Q2 earnings and revenues beat estimates, driven by Innovative Medicine strength and…

J&J falls despite a beat-and-raise quarter. Why were raising our price target anyways

Johnson & Johnsons quarter was imperfect, but enough is going right to validate our ownership of the stock.…

ROUNDUP: Johnson & Johnson profitiert von Krebsmitteln - hebt Jahresziele an

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson hat sich im zweiten Quartal trotz…

Johnson & Johnson’s Spravato sales growth supports psychedelic drug opportunity: Jefferies

Psychedelic drug developers including AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC), Compass Pathways (NASDAQ:CMPS) and Cybin Inc. (NYSE-A:CYBN, FRA:R7E) could...…

Johnson & Johnson Q2-Zahlen: Ausblick erneut leicht angehoben

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson & Johnson profitiert weiterhin von Krebsmitteln - hebt Jahresziele an

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson hat sich im zweiten Quartal trotz…

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Johnson & ?Johnson also increased its full-year sales and ?profit ?forecast.…

Johnson & Johnson beats Q2 estimates, raises full-year 2026 guidance

Johnson & Johnson (NYSE:JNJ) reported better-than-expected second quarter results and raised its full-year 2026 outlook, as strong pharmaceutical sales...…

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as strong growth from immunology drug…

Tech Futures Rise With Nasdaq At Key Level; Oil Pushes Above $80

ASML, Johnson & Johnson, PayPal lead early movers on news.…

Johnson & Johnson Aktie: Wachsende Zuversicht

Toronto (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von RBC Capital Markets:RBC Capital habe das Kursziel für die Aktie von Johnson &…

Is Johnson & Johnson Stock Poised for New Highs as Q2 Results Approach?

After hitting fresh all-time highs last week, investors are turning their attention to JNJs Q2 report, which is scheduled for…

Q2 Earnings Season Arrives: Can Results Match Upbeat Expectations?

The big banks dominate this weeks reporting docket, though several notable companies from other sectors will also report, including Netflix,…

Johnson Service backs outlook despite hospitality weakness

Johnson Service Group plc (LSE:JSG) said it remained on track to deliver its 2026 margin target despite continued weakness in…

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

Johnson & Johnson (JNJ) closed at $263.4 in the latest trading session, marking a -1.44% move from the prior day.…